Home/Filings/4/0001415889-24-022010
4//SEC Filing

Eichenfield Lawrence 4

Accession 0001415889-24-022010

CIK 0001419041other

Filed

Aug 21, 8:00 PM ET

Accepted

Aug 22, 4:12 PM ET

Size

5.9 KB

Accession

0001415889-24-022010

Insider Transaction Report

Form 4
Period: 2024-08-20
Transactions
  • Award

    Stock Option (right to buy)

    2024-08-20+50,00050,000 total
    Exercise: $0.34Exp: 2034-08-20Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. "Date of Grant" shall mean August 20, 2024.

Issuer

Forte Biosciences, Inc.

CIK 0001419041

Entity typeother

Related Parties

1
  • filerCIK 0001814892

Filing Metadata

Form type
4
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 4:12 PM ET
Size
5.9 KB